Segment by Type
Tetrahydrocannabinol (THC)
Cannabidiol (CBD)
Segment by Application
Pain
Arthritis
Neurological Disease (Epilepsy, Multiple Sclerosis and Other Neurological Applications)
Others
By Company
BOL Pharma
Tilray
Medreleaf Corporation
Aurora Cannabis, Inc
Canopy Growth Corporation
Insys Therapeutics, Inc
Aphria, Inc
MGC Pharmaceuticals Limited
GW Pharmaceuticals, plc
Medical Marijuana Inc
Medipharm Labs
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
1.1 Medical Cannabis Product Introduction
1.2 Market by Type
1.2.1 Global Medical Cannabis Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Tetrahydrocannabinol (THC)
1.2.3 Cannabidiol (CBD)
1.3 Market by Application
1.3.1 Global Medical Cannabis Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Pain
1.3.3 Arthritis
1.3.4 Neurological Disease (Epilepsy, Multiple Sclerosis and Other Neurological Applications)
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Medical Cannabis Sales Estimates and Forecasts 2017-2028
2.2 Global Medical Cannabis Revenue Estimates and Forecasts 2017-2028
2.3 Global Medical Cannabis Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Medical Cannabis Sales by Region
2.4.1 Global Medical Cannabis Sales by Region (2017-2022)
2.4.2 Global Sales Medical Cannabis by Region (2023-2028)
2.5 Global Medical Cannabis Revenue by Region
2.5.1 Global Medical Cannabis Revenue by Region (2017-2022)
2.5.2 Global Medical Cannabis Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Medical Cannabis Sales by Manufacturers
3.1.1 Global Top Medical Cannabis Manufacturers by Sales (2017-2022)
3.1.2 Global Medical Cannabis Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Medical Cannabis in 2021
3.2 Global Medical Cannabis Revenue by Manufacturers
3.2.1 Global Medical Cannabis Revenue by Manufacturers (2017-2022)
3.2.2 Global Medical Cannabis Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Medical Cannabis Revenue in 2021
3.3 Global Medical Cannabis Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Medical Cannabis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Medical Cannabis Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Medical Cannabis Sales by Type
4.1.1 Global Medical Cannabis Historical Sales by Type (2017-2022)
4.1.2 Global Medical Cannabis Forecasted Sales by Type (2023-2028)
4.1.3 Global Medical Cannabis Sales Market Share by Type (2017-2028)
4.2 Global Medical Cannabis Revenue by Type
4.2.1 Global Medical Cannabis Historical Revenue by Type (2017-2022)
4.2.2 Global Medical Cannabis Forecasted Revenue by Type (2023-2028)
4.2.3 Global Medical Cannabis Revenue Market Share by Type (2017-2028)
4.3 Global Medical Cannabis Price by Type
4.3.1 Global Medical Cannabis Price by Type (2017-2022)
4.3.2 Global Medical Cannabis Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Medical Cannabis Sales by Application
5.1.1 Global Medical Cannabis Historical Sales by Application (2017-2022)
5.1.2 Global Medical Cannabis Forecasted Sales by Application (2023-2028)
5.1.3 Global Medical Cannabis Sales Market Share by Application (2017-2028)
5.2 Global Medical Cannabis Revenue by Application
5.2.1 Global Medical Cannabis Historical Revenue by Application (2017-2022)
5.2.2 Global Medical Cannabis Forecasted Revenue by Application (2023-2028)
5.2.3 Global Medical Cannabis Revenue Market Share by Application (2017-2028)
5.3 Global Medical Cannabis Price by Application
5.3.1 Global Medical Cannabis Price by Application (2017-2022)
5.3.2 Global Medical Cannabis Price Forecast by Application (2023-2028)
6 North America
6.1 North America Medical Cannabis Market Size by Type
6.1.1 North America Medical Cannabis Sales by Type (2017-2028)
6.1.2 North America Medical Cannabis Revenue by Type (2017-2028)
6.2 North America Medical Cannabis Market Size by Application
6.2.1 North America Medical Cannabis Sales by Application (2017-2028)
6.2.2 North America Medical Cannabis Revenue by Application (2017-2028)
6.3 North America Medical Cannabis Market Size by Country
6.3.1 North America Medical Cannabis Sales by Country (2017-2028)
6.3.2 North America Medical Cannabis Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Medical Cannabis Market Size by Type
7.1.1 Europe Medical Cannabis Sales by Type (2017-2028)
7.1.2 Europe Medical Cannabis Revenue by Type (2017-2028)
7.2 Europe Medical Cannabis Market Size by Application
7.2.1 Europe Medical Cannabis Sales by Application (2017-2028)
7.2.2 Europe Medical Cannabis Revenue by Application (2017-2028)
7.3 Europe Medical Cannabis Market Size by Country
7.3.1 Europe Medical Cannabis Sales by Country (2017-2028)
7.3.2 Europe Medical Cannabis Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Medical Cannabis Market Size by Type
8.1.1 Asia Pacific Medical Cannabis Sales by Type (2017-2028)
8.1.2 Asia Pacific Medical Cannabis Revenue by Type (2017-2028)
8.2 Asia Pacific Medical Cannabis Market Size by Application
8.2.1 Asia Pacific Medical Cannabis Sales by Application (2017-2028)
8.2.2 Asia Pacific Medical Cannabis Revenue by Application (2017-2028)
8.3 Asia Pacific Medical Cannabis Market Size by Region
8.3.1 Asia Pacific Medical Cannabis Sales by Region (2017-2028)
8.3.2 Asia Pacific Medical Cannabis Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Medical Cannabis Market Size by Type
9.1.1 Latin America Medical Cannabis Sales by Type (2017-2028)
9.1.2 Latin America Medical Cannabis Revenue by Type (2017-2028)
9.2 Latin America Medical Cannabis Market Size by Application
9.2.1 Latin America Medical Cannabis Sales by Application (2017-2028)
9.2.2 Latin America Medical Cannabis Revenue by Application (2017-2028)
9.3 Latin America Medical Cannabis Market Size by Country
9.3.1 Latin America Medical Cannabis Sales by Country (2017-2028)
9.3.2 Latin America Medical Cannabis Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Medical Cannabis Market Size by Type
10.1.1 Middle East and Africa Medical Cannabis Sales by Type (2017-2028)
10.1.2 Middle East and Africa Medical Cannabis Revenue by Type (2017-2028)
10.2 Middle East and Africa Medical Cannabis Market Size by Application
10.2.1 Middle East and Africa Medical Cannabis Sales by Application (2017-2028)
10.2.2 Middle East and Africa Medical Cannabis Revenue by Application (2017-2028)
10.3 Middle East and Africa Medical Cannabis Market Size by Country
10.3.1 Middle East and Africa Medical Cannabis Sales by Country (2017-2028)
10.3.2 Middle East and Africa Medical Cannabis Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 BOL Pharma
11.1.1 BOL Pharma Corporation Information
11.1.2 BOL Pharma Overview
11.1.3 BOL Pharma Medical Cannabis Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 BOL Pharma Medical Cannabis Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 BOL Pharma Recent Developments
11.2 Tilray
11.2.1 Tilray Corporation Information
11.2.2 Tilray Overview
11.2.3 Tilray Medical Cannabis Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Tilray Medical Cannabis Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Tilray Recent Developments
11.3 Medreleaf Corporation
11.3.1 Medreleaf Corporation Corporation Information
11.3.2 Medreleaf Corporation Overview
11.3.3 Medreleaf Corporation Medical Cannabis Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Medreleaf Corporation Medical Cannabis Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Medreleaf Corporation Recent Developments
11.4 Aurora Cannabis, Inc
11.4.1 Aurora Cannabis, Inc Corporation Information
11.4.2 Aurora Cannabis, Inc Overview
11.4.3 Aurora Cannabis, Inc Medical Cannabis Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Aurora Cannabis, Inc Medical Cannabis Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Aurora Cannabis, Inc Recent Developments
11.5 Canopy Growth Corporation
11.5.1 Canopy Growth Corporation Corporation Information
11.5.2 Canopy Growth Corporation Overview
11.5.3 Canopy Growth Corporation Medical Cannabis Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Canopy Growth Corporation Medical Cannabis Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Canopy Growth Corporation Recent Developments
11.6 Insys Therapeutics, Inc
11.6.1 Insys Therapeutics, Inc Corporation Information
11.6.2 Insys Therapeutics, Inc Overview
11.6.3 Insys Therapeutics, Inc Medical Cannabis Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Insys Therapeutics, Inc Medical Cannabis Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Insys Therapeutics, Inc Recent Developments
11.7 Aphria, Inc
11.7.1 Aphria, Inc Corporation Information
11.7.2 Aphria, Inc Overview
11.7.3 Aphria, Inc Medical Cannabis Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Aphria, Inc Medical Cannabis Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Aphria, Inc Recent Developments
11.8 MGC Pharmaceuticals Limited
11.8.1 MGC Pharmaceuticals Limited Corporation Information
11.8.2 MGC Pharmaceuticals Limited Overview
11.8.3 MGC Pharmaceuticals Limited Medical Cannabis Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 MGC Pharmaceuticals Limited Medical Cannabis Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 MGC Pharmaceuticals Limited Recent Developments
11.9 GW Pharmaceuticals, plc
11.9.1 GW Pharmaceuticals, plc Corporation Information
11.9.2 GW Pharmaceuticals, plc Overview
11.9.3 GW Pharmaceuticals, plc Medical Cannabis Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 GW Pharmaceuticals, plc Medical Cannabis Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 GW Pharmaceuticals, plc Recent Developments
11.10 Medical Marijuana Inc
11.10.1 Medical Marijuana Inc Corporation Information
11.10.2 Medical Marijuana Inc Overview
11.10.3 Medical Marijuana Inc Medical Cannabis Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Medical Marijuana Inc Medical Cannabis Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Medical Marijuana Inc Recent Developments
11.11 Medipharm Labs
11.11.1 Medipharm Labs Corporation Information
11.11.2 Medipharm Labs Overview
11.11.3 Medipharm Labs Medical Cannabis Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Medipharm Labs Medical Cannabis Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Medipharm Labs Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Medical Cannabis Industry Chain Analysis
12.2 Medical Cannabis Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Medical Cannabis Production Mode & Process
12.4 Medical Cannabis Sales and Marketing
12.4.1 Medical Cannabis Sales Channels
12.4.2 Medical Cannabis Distributors
12.5 Medical Cannabis Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Medical Cannabis Industry Trends
13.2 Medical Cannabis Market Drivers
13.3 Medical Cannabis Market Challenges
13.4 Medical Cannabis Market Restraints
14 Key Findings in The Global Medical Cannabis Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Research Methodology
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analysing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.